Startup accelerator & VC Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Olivier Millet fintech | Other 25 Sep 2021 | | |
 | EBD it services, IT Services and IT Consulting | Not capitalistic Not partnership Event 7 Nov 2019 | | |
 | mind Health healthtech, Online Audio and Video Media | Capitalistic Not partnership Not event 9 Oct 2024 | | |
 | Sensome deeptech, healthtech, Medical Equipment Manufacturing | Capitalistic Not partnership Not event 16 Jul 2022 | | |
 | UI Investissement Venture Capital and Private Equity Principals | Other 25 Oct 2022 | | |
 | Ganymed Robotics deeptech, Medical Equipment Manufacturing | Other 30 Jun 2022 | | |
 | SFPIM fintech, Financial Services | Other 16 Sep 2024 | | |
 | Ysios Capital Venture Capital and Private Equity Principals | Other 12 May 2024 | | |
 | Tiendanimal pettech, retail, Retail | Other 3 May 2018 | | |
 | Asabys Partners Venture Capital and Private Equity Principals | Other 28 Feb 2023 | | |